Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

Prerandomization renal biopsy specimens were examined in 102 patients upon entry into prospective therapeutic trials of lupus nephritis in an attempt to identify early predictors of renal failure outcome. All 11 renal failures occurred among the 72 individuals with diffuse proliferative or membranoproliferative glomerulonephritis (DPGN/MPGN); thus, these patients were at modestly, but significantly, increased risk of endstage renal disease compared to those with focal proliferative, membranous, or mesangial glomerulonephritis. Considering the low incidence of endstage renal disease among patients with DPGN/MPGN, we sought to refine the prognostic information obtained from renal morphology by semiquantitative scoring of individual histologic features and by derivation of composite histologic scores specified by Activity (AI) and Chronicity (CI) Indices. Among the 72 patients with DPGN/MPGN, the composite AI was more strongly predictive of renal failure than were the individual active histologic features; cellular crescents and extensive fibrinoid necrosis yielded positive associations, while endocapillary proliferation, leucocytic exudation, and hyaline thrombi in glomeruli and interstitial inflammation by themselves did not emerge as useful prognostic indicators. However, chronicity items (glomerular sclerosis, fibrous crescents, tubular atrophy, and interstitial fibrosis) considered individually, as well as in the composite CI, were highly predictive of renal failure outcome. Particularly striking was the prognostic value of tubular atrophy; all 11 renal failures were among the 43 patients with tubular atrophy on prerandomization renal biopsy. While no single pathologic variable improved outcome predictions among those with tubular atrophy, examination for interactions among variables revealed that glomerular sclerosis and cellular crescents had a synergistic effect which augmented the prognostic information derived from analysis of tubular atrophy alone.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  A. Cohen,et al.  THE NEPHROPATHY OF SYSTEMIC LUPUS ERYTHEMATOSUS: An Assessment by Clinical, Light and Electron Microscopic Criteria , 1967 .

[2]  A. Steinberg,et al.  Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. , 1983, Annals of internal medicine.

[3]  V. Pollak,et al.  Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis. , 1961, The Journal of laboratory and clinical medicine.

[4]  D. E. Cheatum,et al.  Renal histology and clinical course of systemic lupus erythematosus. A prospective study. , 1973, Arthritis and rheumatism.

[5]  K. E. Holley,et al.  Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. , 1972, Annals of internal medicine.

[6]  A. Steinberg,et al.  A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis. , 1974, Arthritis and rheumatism.

[7]  A. Steinberg,et al.  Systemic Lupus Erythematosus: Evolving Concepts , 1979 .

[8]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[9]  D. Droz,et al.  The course of lupus nephritis: contribution of serial renal biopsies. , 1976, Advances in nephrology from the Necker Hospital.

[10]  N. Ordóñez,et al.  Changing histopathology patterns in lupus nephropathy. , 1978, Clinical nephrology.

[11]  V. Pollak,et al.  THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. , 1964, The Journal of laboratory and clinical medicine.

[12]  R. Mccluskey,et al.  The clinical course of the proliferative and membranous forms of lupus nephritis. , 1970, Annals of internal medicine.

[13]  J. Hayslett,et al.  PROGNOSTIC INDICES IN LUPUS NEPHRITIS , 1976, Medicine.

[14]  Q. Whiting-O'Keefe,et al.  The information content from renal biopsy in systemic lupus erythematosus. , 1982, Annals of internal medicine.

[15]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[16]  Elisa T. Lee,et al.  Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.

[17]  B. Zweiman,et al.  The prognosis of lupus nephritis. Role of clinical-pathologic correlations. , 1968, Annals of internal medicine.

[18]  A. Steinberg,et al.  Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months. , 1975, Annals of internal medicine.

[19]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[20]  J. Bach,et al.  Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. , 1978, The American journal of medicine.

[21]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[22]  D. Cox Regression Models and Life-Tables , 1972 .

[23]  A. Steinberg,et al.  Cyclophosphamide in lupus nephritis: a controlled trial. , 1971, Annals of internal medicine.

[24]  D. Baldwin,et al.  Lupus nephritis: Clinical course as related to morphologic forms and their transitions , 1977 .

[25]  V. Pollak,et al.  Lupus nephritis: a clinical and pathologic study based on renal biopsies. , 1957, Medicine.

[26]  J. Klippel,et al.  Prognostic factors in lupus nephritis. Contribution of renal histologic data. , 1983, The American journal of medicine.

[27]  D. Wallace,et al.  Lupus nephritis: Experience with 230 patients in a private practice from 1950 to 1980 , 1982 .

[28]  C. Chantler,et al.  Systemic lupus with nephritis: a long-term study. , 1979, The Quarterly journal of medicine.

[29]  Balow Je Therapeutic trials in lupus nephritis. Problems related to renal histology, monitoring of therapy and measures of outcome. , 1981 .

[30]  D. Estes,et al.  THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS , 1971, Medicine.

[31]  V. Pollak,et al.  THE REPRODUCIBILITY OF SEMIQUANTITATIVE ANALYSES OF RENAL HISTOLOGY. , 1964, Nephron.

[32]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[33]  Striker Ge,et al.  The course of lupus nephritis: a clinical-pathological correlation of fifty patients. , 1973 .

[34]  M. Liang,et al.  Marginal benefit of renal biopsy in systemic lupus erythematosus. , 1978, Archives of internal medicine.

[35]  G. Appel,et al.  RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A Study of 56 Patients Emphasizing Histologic Classification , 1978, Medicine.

[36]  A. Steinberg,et al.  Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. , 1982, Annals of internal medicine.

[37]  P. Kincaid‐smith,et al.  Lupus nephritis: clinical course in relation to treatment. , 1973, Perspectives in nephrology and hypertension.

[38]  B. Burke,et al.  Systemic lupus erythematosus within the first two decades of life. , 1977, The American journal of medicine.

[39]  E. Gehan A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.